I would appreciate your views on TRIN for an investor seeking income as part of a diversified portfolio, and recommendations for alternatives to TRIN in the same broad category if you don't think that TRIN is an interesting investment.
Q: Some of the metrics look good, but PE 157 scares me.
On previous occasion, refering to BN, you stated that their high PE is due to a peculiar accounting..
Would you say that's the case here too?
thanks Jerry
Q: The company has set a release date of earnings as of March 25th. That is more than a month past the normal date.
What maybe causing the delay? This release has the stock down 7 %.
Do you expect the price to fall further?
Is GSY a buy, sell or hold? What might be good buy price?
Thank you
Q: I see that GSY stock to a big drop today. The stock is now reaching a very strong support level at about $100. Is this now a buying opportunity? Is it better to wait for the Q4 results?
Thanks John.
Q: Hi team,
Is gsy tanking today from trumps tariff uncertainty? Or is the late earnings date release now of concern? Many growth names are again in free fall today I am assuming must of it is back to trade uncertainty and again software sell off.
Q: this company has dropped quite a bit in the last month. Pays a good dividend. Seems to me that the share price is lagging the earnings growth. No debt. what am I missing?
thanks Dave
Q: Both GSY (go easy) and Well health float at annual lows. When are they expected to report? Is the current valuation "fair value" given what we know today? or are they trading at a discount
Q: I am seeking to increase my international exposure and financials. What do you think of this company at this current price? To what extent are current metrics comparable to other financials such as PRL or GSY? It is significantly lower than the IPO price and the prospects for growth has not disappeared. Buy, Sell, Hold? If a buy, would you recommend buying a third, half, or full position?
Q: I see that the company recently announced another div increase -good news but the bump has quickly worn off. Earnings are still good and P/E now below 10. What is the catalyst to get the stock off the mat?
Q: I am baffled by the decline here since announcing a dividend increase Feb11. It is down 15% + since. Why? No eps till Mar 2. Surely they would not raise it if the results were going to be less than expected. Your thoughts. Thanks
Q: Why is there a need for an "investigation" into Galaxy? Simply for missing its estimates? And yet that seems to be what everyone is pointing at. How can one be held to account for predicting what is almost inevitably unpredictable when the market goes wonky? I don't see that GLXY has done anything wrong, but what do I know?
If you have posted an answer directly about this question, please point me to it, as I've failed to find it. Thanks, as always.